| Literature DB >> 35054593 |
Ecaterina Matei1, Cristina Ileana Covaliu-Mierla2, Anca Andreea Ţurcanu3, Maria Râpă1, Andra Mihaela Predescu1, Cristian Predescu1.
Abstract
This paper presents a comprehensive literature review surveying the most important polymer materials used for electrospinning processes and applied as membranes for the removal of emerging pollutants. Two types of processes integrate these membrane types: separation processes, where electrospun polymers act as a support for thin film composites (TFC), and adsorption as single or coupled processes (photo-catalysis, advanced oxidation, electrochemical), where a functionalization step is essential for the electrospun polymer to improve its properties. Emerging pollutants (EPs) released in the environment can be efficiently removed from water systems using electrospun membranes. The relevant results regarding removal efficiency, adsorption capacity, and the size and porosity of the membranes and fibers used for different EPs are described in detail.Entities:
Keywords: electrospinning; emerging pollutants; membranes
Year: 2022 PMID: 35054593 PMCID: PMC8778428 DOI: 10.3390/membranes12010067
Source DB: PubMed Journal: Membranes (Basel) ISSN: 2077-0375
Figure 1Influence of emerging pollutants (EPs) on environments.
Advantages and future challenges for applying conventional and non-conventional processes for EP removal.
| Water Treatment Technologies for the Removal of Emerging Pollutents (EPS) | |||
|---|---|---|---|
| Conventional Processes | Non-Conventional Processes | ||
|
| |||
|
|
| ||
|
|
|
|
|
|
Greener than chlorination Lower operational costs than AOPs |
Low efficiencies for pharmaceuticals and beta blockers Large amount of sludge containing EPs |
Low energy consumption, low operational and maintenance costs High removal efficiency for estrogens and pathogens |
Clogging, solids entrapment, sediments formation Seasonal dependent, chemical precipitation, biofilm growth Large areas of land needed and long retention time |
|
|
| ||
|
|
|
|
|
|
Removal of a broad range of EPs Removal of residual disinfection/oxidation products No generation of toxic active products |
High operation and maintenance costs Regeneration and disposal of high sludge amounts that increase total costs by 50–60% |
Effective for the removal of biorecalcitrant EPs Small footprint |
High energy consumption and fouling control of heat and mass transfer High aeration costs and roughness of membrane Low efficiencies for pharmaceutical pollutants |
|
| |||
|
|
| ||
|
Resource recovery from algal biomass used as fertilizer Efficient effluent and no risk of acute toxicity |
Removal efficiencies affected by cold season EPs not degraded properly | ||
|
| |||
|
|
| ||
|
|
|
|
|
|
Short degradation rate |
High energy, operational and maintenance costs Toxic disinfection by-products Interference of radical scavengers |
Minimum cost, simple and better for pathogen elimination Low operational and maintenance costs |
High energy consumption and fouling control of heat and mass transfer High aeration costs and roughness of membrane Low efficiencies for pharmaceutical pollutants |
|
|
| ||
|
|
|
|
|
|
Reduced turbidity due to suspended inorganic and organic particles Increased sedimentation rate through suspended solid particle formation |
Ineffective micropollutant removal Large amount of sludge Introduction of coagulant slats in the aqueous phase |
Low operational and maintenance cost |
Tertiary filters may be prerequisite after elucidation, reliant on the sewage necessities |
|
| |||
|
|
| ||
|
Degradation and mineralization of EPs |
Formation of chloro and sulfato-Fe(III) complexes, in the presence of chloride and sulphate ions | ||
|
| |||
|
|
| ||
|
Strong affinity to EPs in the presence of H2O2 Selective oxidant favoring disinfection and sterilization properties |
High energy consumption, formation of oxidative by-products | ||
|
| |||
|
|
| ||
|
Sunlight can be used Degrading persistent organic compounds High reaction rates upon using catalyst Low price and chemical stability of TiO2 catalyst and easier recovery |
Difficult to treat large volume of wastewater Cost associated with artificial UV lamps and electricity Hard to separate and reuse from slurry suspension | ||
|
| |||
|
|
| ||
|
|
|
|
|
|
Can remove EPs and pathogens |
Not efficient in removing some large EPs |
Significant reduction of load losses of up to max. 80 mbar (as opposed to conventional systems); Membrane resistance temperature of approx. 80 °C; Minimum system maintenance costs Low energy consumption |
Limited testing and upscale implementation data |
|
| |||
|
|
| ||
|
Treating saline water and wastewater treatment plants (WWTP) influents Can remove dye stuff and pesticides |
High energy demand, disposal issues Limited application in pharmaceuticals removal | ||
|
| |||
|
|
| ||
|
Treating saline water and WWTP influents Can remove PCPs, endocrine disrupting compounds (EDCs) and pharmaceuticals |
High energy demand, disposal issues Corrosive nature of finished water and lower pharmaceutical removal | ||
Figure 2Electrospinning process steps applied for membrane fabrication.
Figure 3Main materials applied for the electrospinning process.
Examples of nanofibers with efficiencies in adsorption and advanced decontamination processes for EP.
| Type of Process | Type of Nanofiber/Method/Characteristics | EP Types/Category, Performances |
|---|---|---|
| Adsorption [ | Anionic nanofibrous nonwoven adsorbent: alkali lignin and poly(vinyl alcohol) (PVA). Method: 4 h thermal treatment (180 °C), 120 min chemical treatment (citrate buffer solution 0.5 M, pH 4.5). Diameter: 156 nm. | Pharmaceutical contaminant (32 ppm fluoxetine), contact time 1 h, Adsorption efficiency: 70%. |
| Adsorption [ | Electrospun PAN nanofiber membranes modified with β-cyclodextrin (β-CD) crosslinked with citric acid. Method: PAN and PAN-CD (ratio 80:20) prepared in DMF solution, 12 h at room temperature. Citric acid (0.1 M) as crosslinker and sulfuric acid (0.05 M) as activator. Diameter: 557 nm PAN and 497 nm PAN with β-CD. | Atrazine (5–25 ppm), adsorption capacity: PAN 0.603 mg/g, PAN-CD 0.817 mg/g. Adsorption efficiency: PAN 67% and PAN-CD 91%. |
| Adsorption [ | Porous β-cyclodextrin modified cellulose nano-fiber membrane (CA-P-CDP). Method: prepared PCDP was dispersed in a mixture of prepared CA membrane and NaOH solution, 2 h. Freeze-drying for 24 h. Diameter: 462 ± 94 nm for nanofibers of CA membrane. | Bisphenol A (BPA), S (BPS), F (BPF): 1 mg/L, adsorption capacities (15 min): 50.37, 48.52, 47.25 mg/g. |
| Adsorption [ | Composite nanofiber membrane (CNM). Method: polymerization of βCD using epichlorohydrin (EP) and deposited β-cyclodextrin-epichlorohydrin (βCDP) on PES ultrafiltration (UF) membranes via electrospinning. Diameter: 90–250 nm for surface of CNMs, cross Section 250 thickness of about 80 μm. | Radiolabeled steroid hormones. |
| Adsorption [ | chitosan/poly (vinyl alcohol) glutaraldehyde-crosslinked electrospun nanofibers (GCCPN). Minimum diameters: 6–18 nm, 75/25 chitosan/PVA ratio. | 50–250 mg/L TC. Maximum adsorption: 102 mg/g. Adsorption efficiency: 34–97%. |
| Adsorption [ | Polyporous electrospun fibrous membranes via electrospinning: methoxy polyethylene glycol-poly(lactide-co-glycolide) (MPEG-PLGA), poly(D,L-lactide-co-glycolide) (PLGA) and poly(D,L-lactide) (PDLLA). Triblock copolymer/polymers/solvent weight ratio: 1/10/90, 1.5/15/85 and 2/20/80, dissolved in methylene dichloride, vigorous stirring. Diameters: 740, 530 and 470 nm for MPEG-PLGA, PLGA, and PDLLA. | 10 g/L triclosan (TCS). Maximum adsorption capacities MPEG-PLGA, PLGA and PDLLA: 130, 93 and 99 mg/g. Removal efficiency: over 90% with decreasing at 80% in case of competitive adsorption. |
| Adsorption [ | Fiber-adsorbent from cellulose acetate (CA) membrane via electrospinning. Method: homogeneous CA solution from cellulose acetate added to 4:1 chloroform/methanol mixture, stirring and sonication. Adding under vigorous stirring of 1-Butyl-3-methylimidazolium hexafluorophosphate (BMIPF6) used as ionic liquid to obtain a homogeneous CA-BMIPF6 solution as precursor. Diameters: 100−400 nm, more than 10 cm long. Average pores diameter: 3 nm. | 25 mg/L Triclosan (TCS), Adsorption capacity: 797.7 mg/g. |
| Adsorption [ | Fiber membrane with interconnected mesopores based on an electrospun zeolitic imidazolate framework-8 (ZIF-8)/PAN fibers integrated into PVP. Method: zinc salt and 2-methylimidazole as precursors into PVP to obtain electrospun fiber membrane, PVP removal at 50 °C for 24 h, membrane soaked into methanol 3 days, dried at 100 °C in vacuum. Diameters: 36–112 nm. | TC, maximum adsorption capacity: 885.24 mg/g, after 4 h. Adsorption efficiency 97% after 10 cycles. |
| Adsorption [ | Alkali lignin AL and poly (vinyl alcohol) PVA nanofibers. Method: mixing 2 solutions: AL dissolution in NaOH 1 M (1) and PVA in water (2), heated to 80 °C, 60 min. Mass ratio of 1:1 of (1): (2) for electrospinning, refrigerated 4 °C max 1 month. Electrospun fiber stabilization: heating at 160 °C, 3 h, membranes immersion into sodium citrate buffer pH 4.5, 3 h. Diameters: 183 ± 5 nm by electrospinning, 156 ± 5 nm by thermal process, 188 ± 10 nm by chemical stabilization. | Fluoxetine (FLX), venlafaxine (VEN), carbamazepine (CAR), ibuprofen (IBU). Individual adsorption: FLX: 78.24 ±1.35 mg/g (78%), VEN: 49.76 ± 2.80, CAR: 8.04 ± 0.01, IBU: 5.00 ± 0.46 mg/g. Desorption tests: 90% recovery. |
| Adsorbtion [ | 4 types of nanofiber mats metalorganic frameworks (MOFs): polydopamine (PDA) modified electrospun PVA/SiO2 as organic inorganic hybrid nanofiber. Method: electrospun PVA/SiO2 nanofibers immersed in PDA 12 h, autoclaved with ionic liquids: MIL-53(Al), Uio-66-NH2 and NH2-MIL-125(Ti). Deposition efficiency: MIL-53(Al) > NH2-MIL-125(Ti) > UiO-66-NH2 > ZIF-8. Diameters: 0.3–0.5 mm thick for PVA/SiO2 nanofiber mat, >1000 nm for 3D-PDA-modified PVA/SiO2 nanofibers. | Chloramphenicol (CAP), equilibrium adsorption capacities: ZIF-8 (13.9 mg/g) < UiO-66-NH2 (25.1 mg/g) < NH2-MIL-125(Ti) (49.5 mg/g) < MIL-53(Al) (79.5 mg/g). |
| Adsorption [ | Fe3O4/polyacrylonitrile (PAN) composite nanofibers. Method: two-step process: electrospinning (8 h) and solvothermal method. The fibrous mat collected after electrospinning cut to 5 cm × 2 cm, immersed in FeCl3 dissolved in DEG, added Na3Cit and anhydrous sodium acetate, 80 °C, autoclave. Average diameter: 500 nm (single NF), 60 nm (Fe3O4 NPs), 20 nm (coating thickness). | TC. Maximum adsorption capacity (Langmuir isotherm): 257.07 mg/g, pH 6. 5 cycles of adsorption-desorption. |
| Adsorption [ | polyimide (PI)-based carbon nanofibers (CNFs). Method: electrospining polyamic acid solutions, thermal imidization and carbonization. Polyamic acid PAA nanofibers dried overnight, imidization of PAA fibers and carbonization at different temperatures and time intervals. High specific surface area: 715.89 m2/g. | 2,4-DCP and TC, different temperatures. Maximum adsorption: 483.09 mg/g (2,4-DCP), 146.63 mg/g (TC). Desorption: 5 consecutive cycles. |
| Adsorption [ | Zeolitic imidazolate framework-8 (ZIF-8) functionalized composite electrospun fiber. Method: adsorbent polydopamine (PDA) onto the surface of PAN electrospun nanofibers (PDA/PAN). PDA/PAN fibers immersed in Zn (NO3)2 solution 1 h, room temperature, adding 2-methylimidazole solution, heated, 40 min (ZIF-8 crystals onto fiber surface), washed and dried overnight. Average diameter: 349 nm. | TC: 478.18 mg/g, adsorption efficiency: 85%. 5 five adsorption/desorption cycles. |
| Adsorption [ | Electrospun montmorillonite-impregnated cellulose acetate nanofiber | Ciprofloxacin (CIP). Adsorption efficiency: 76% pH 6. Maximum adsorption capacity: 13.8 mg/g. Reusability capacity. |
| Adsorption [ | Graphene oxide (GO)/poly(vinylidene fluoride) (PVDF) electrospun nanofibrous membranes (ENMs). Method: GO-PVDF blend solution from mixture of PVDF in | 5–500 mg/L TC |
| Adsorption [ | Polyimide modified carbon nanofibers composites. Method: electrospinning, facile hydrothermal process and carbonization. β-cyclodextrin (β-CD) as carbon precursor for hydrothermal carbon nanoparticles (HTCNPs) and PI (polyimide) fibers as support scaffold for HTCNPs via hydrothermal process, carbonization under nitrogen atmosphere. Diameters: 2–10 nm (mesoporus). | TC, maximum adsorption capacities: 543.48 mg/g, removal efficiency: 82.32%. The basic fiber skeleton of porous structure maintained for 5 consecutive cycles. |
| Adsorption [ | Carbon nanofibers (CNFs). Method: PAN polymer solutions in | CIP, BPA, 2-chlorophenol (2-CP). Maximum adsorption capacities: 2-CP (6.18 mmol/g) > BPA (4.82 mmol/g) > CIP (0.68 mmol/g). |
| Adsorption [ | Electrospun PVA fibers. Method: Mondia whitei polymeric extract frozen at −80 °C, dried, blended with PVA at different ratios, dissolved in formic acid, stirring, 60 °C, 2 h. Average diameter: 99 ± 0.023 nm. | 0.5–1.25 mg/L for each 13 antiretrovirals and related drugs from wastewater (influent and effluent). Maximum adsorption capacity: 75–320 mg/g. The removal efficiency after spiking 25 mL of the real wastewater sample (effluent and influent) with 10 mg/L of standard mixture solutions. |
| Adsorption [ | PVA nanofibers. Methoad: lkali lignin (AL) and PVA solutions (50:50). | Fluoxetine, removal efficiency: 70%. |
| Adsorption [ | Carbon nanofiber (CNF)–carbon nanotube (CNT) composite based on PAN polymer solution via electrospinning and carbonization. | 10 CECs (atrazine, sulfamethoxazole etc.). Removal efficiency > 90%. |
| Adsorption [ | PAN–CD nanofibers (PAN nanofiber modified with cyclodextrin). Diameters: 497 nm. | 10 mg/L atrazine. Removal efficiency: 91.46%. |
| Adsorption [ | Cellulose nanofibers incorporating CD. | (BPA), bisphenol S (BPS), and bisphenol F (BPF). Maximum adsorption capacities: 50.37 mg/g (BPA), 48.52 mg/g (BPS), 47.25 mg/g (BPF), pH 7. |
| Adsorption [ | UF membrane. Method: electrospinning for polyethersulfone (PES) nanofibers preparation with CD deposited over PES, with different crosslinking agents (epichlorohydrin, trimethylolpropane, etc.). | Steroid hormones. Removal efficiency: 95%, estradiol, 5 h. |
| Adsorption [ | PVDF photocatalytic stainless-steel filter. Method: hot-pressed TiO2 nanofibers over metal filter with PVDF as binder. | Cimetidine. Removal efficiency: 90% for 29 µm thickness. |
| Adsorption [ | PAN nanofibers dopped with TiO2 nanoparticles. Method: TiO2 NPs dispersed in polymeric matrix with phthalic acid as dispersant. | 0.5 µM CECs (atrazine, benzotriazole, caffeine, carbamazepine, metoprolol, naproxen, sulfamethoxazole). Efficiency: 90%. |
| Adsorption with oxidation [ | Hollow and porous Fe-doped PAN nanofibers. Method: electrospinning and thermal treatment, activating with peroxymonosulfate (PMS). | BPA. Adsorption and oxidation efficiency: 100%, 6 min. |
| Degradation [ | PVP Fe/Co alloy on PVP nanofibers. | TC, degradations: 100%, 93.12%, 88.38% at 30 mg/L, 40 mg/L, 50 mg/L. |
| Degradation [ | Nanofiber Photocatalyst. Method: disperse graphitic carbon nitride (g-C3N4) into recycled polyethylene terephthalate (PET) solution, electrospinning and hydrothermal treatment. Diameters: 3.7 nm thickness for as-prepared g-C3N4. | 2 × 10−5 mol/L Sulfaquinoxaline (SQX), sulfadiazine (SD), sulfamerazine (SMZ). Degradation rate: 100% SQX, solar irradiation, 2.5 h and about 98% for SD and SMZ at different solar irradiation times. |
| Degradation [ | Porous and hollow one-dimension Fe/N-doped carbon nanofibers (Fe/NCNFs-9). Method: immobilizing Fe-MIL-101 on PAN nanofibers (Fe-MIL-101@PAN) via electrospinning, 900 °C carbonizing. Diameter: Fe-MIL-101: 530 nm. | 20 mg/L BPA completely degraded with PMS peroxymonosulfate (0.2 g/L) as activator and Fe/NCNFs-9 (0.4 g/L) within 6 min. |
| Antibacterial degradation [ | PSf/TiO2/AgNPs nanocomposite substrates as FO membrane. Method: TiO2/AgNP nanocomposite particles using dopamine hydrochloride (DOPA), dispersion with polysulfone PSf, electrospuned on PET nonwoven scaffold. | Tetracycline-resistant genes (TRGs). The rejection under AL-FS (active layer-facing feed solution) and AL-DS (active layer-facing draw solution): 28.53% and 24.48%. |
| Electrochemical degradation [ | ATO/RO composite nanofibers as dimensionally anodes. Method: RuO2 (RO) as primary electrocatalyst with Sb-doped SnO2 (ATO) as support material via dual nozzle electrospinning. Fiber mats preparation: 200 C for 2 h, and 475 °C for 12 h. Avg diameter: 172 nm, primary nanoparticles: 10–30 nm. | 0.25 mM BPA, degradation with current density of 3 mA·cm−2 and ATO/RO (30:1): 100%. |
| Electrochemical degradation [ | Electrospun composite nanofibers base on iron/cobalt alloy nanoparticles (Fe/Co-CNFs) integrated into PVP. Method: 5.0 wt% of ferric and cobalt nitrate as precursor, direct calcination of PVP composite nanofibers, 800 °C, 30 min, reduction atmosphere. | TC, degradation: 97.55%, after 10 cycles of electrocatalytic process, 1.0 V (vs. SCE) voltage, pH 5.0, 0.1 mol L−1 Na2SO4 as electrolyte. |
| Electro-Fenton catalyst [ | Electrospun three-dimensional (3D) nanofiber network. Method: water-resistant 3D PVA nanofiber network preparation from PVA/urea solution, crosslinked in ethanol solution containing glutaraldehyde and HCl. Spongy zero-valent iron (ZVI) preparation: Fe(III) ions reduced complexed with 3D PVA nanofiber network using NaBH4 solution, washed, frozen 2 h. | Sulfathiazole (STZ). Coupled adsorption and electro-catalytic oxidation rate: almost 100%, 5 min. 3D-E-Fenton experiments: 50% STZ adsorption, and total adsorption at 240 min. |
| Electrochemical oxidation [ | Antimony tin oxide doped ruthenium oxide (ATO-RO) nanoparticles incorporated into PVP nanofibers via electrospinning for nanofiber used as anode material for electrochemical oxidation. | 0.25 mM BPA, complete degradation, 20 min electrolysis at 3 mA/cm2 current density. |
| Electrocoagulation [ | PVC tubular carbon nanofibers with activated alumina over PVC support as the anode material for an electrocoagulation system. | caffeine, sulfamethoxazole, acetaminophen. Degradation efficiencies: 95.8%, 94.9%, 79.8%. |
| Photodegradation [ | 8.4 wt% TiO2 coaxial nanofibers using PVA as carrier polymer. | Isoproturon. 38% photocatalytic activity. |
| Photodegradation [ | PVDF/TiO2 Nanocomposite membrane: electrospun titanium dioxide (TiO2) nanofibers onto PVDF flat sheet membrane. Method: hot press technique at 100 °C, 160 °C and 180 °C for 30 min. Photocatalyst TiO2 nanofibers are stabilized onto PVDF membrane as support. | 10 ppm BPA aqueous solution. Degradation efficiency: 63–85%, under UV radiation. |
| Photodegradation [ | ZnO-Carbon composite nanofibers. Method: different precursor polymers solutions (PAN, PS, PVP) dissolved in DMF, addition of 8 wt% Zn(acac)2. Final products: 1D ZnO-X nf (X: PAN, PS or PVP). | 30 ppm Caffeine (pharmaceutical drug). Degradation efficiency: 80% for 1D ZnO-PS nanofiber. |
| Photodegradation and oxidation [ | Photo-catalytical active stainless-steel filter (P-SSF). Method: electrospun TiO2 nanofibers integrated onto SSF surface through hot-press process, using poly (vinylidene fluoride) (PVDF) nanofibers interlayer as binder. | Pharmaceuticals. Cimetidine degradation: 90%, at 10 L/m2 h and 0.1–0.2 kPa. TiO2 NFs thickness from 10 to 29 µm with oxidation of cimetidine from 42% to 90%. Degradation: cimetidine > propranolol > acetaminophen > sulfamethoxazole. |
| Photodegradation [ | Carbon/TiO2 (C/TiO2) nanofiber composite filters. Method: PAN nanofibers with embedded titanium dioxide (TiO2) nanoparticles via electrospinning, carbonization. Filter thickness: 300–1800 μm. | 0.5 μM for each 8 organic micropollutants (atrazine, benzotriazole, caffeine, carbamazepine, DEET, metoprolol, naproxen, and sulfamethoxazole). Degradation: 40–90%, for 300 μm thick filter. |
| Photodegradation [ | Porous nanofibers (g-C3N4@PET). Method: polyethylene glycol (PEG) and polyethylene terephthalate (PET), and graphitic carbon nitride (g-C3N4) via electrospinning, post-processing for PEG removal. Diameters: 2–50 nm. | sulfaquinoxaline (SQX), sulfachloropyridazine, sulfamerazine, sulfadiazine, sulfamethoxydiazine, p-benzoquinone, p-chlorophenol. Degradation: 90%. SQX: 10 consecutive cycles. |
| Photodegradation [ | Photocatalysts membrane. Method: PVDF as support for hot-pressed TiO2 nanofibers. | 10 mg/L BPA, Degradation efficicncy: 63–85%, UV light. |
| Photodegradation [ | ZnO–carbon composite nanofibers. Method: electrospinning with different polymeric precursors (PAN, PS, and PVP), carbon doping efficiency depend on the precursors. | Caffeine, diclofenac. Degardation rate: 80.4%, 2 h for caffeine, 79.5% for diclofenac. |
| Adanced Photodegradation coupled with H2O2 [ | Polylactic acid (PLA)/TiO2 hybrid nanofibers deposited on fiberglass supports. Method: TiO2 nanoparticles added to the PLA solution mixed with acetone/DMF (3:2 ratio), 60 °C, 600 rpm, 4 h. TiO2/PLA solution electrospun onto PLA surface as adhesive between nanofibers and fiberglass surface. | 300 mg/L Ampicillin, pH 3 with peroxide, 2 cycles. Complete degradation. Limitation: degradation of PLA under the photocatalytic conditions. |
| Antibacterial Photodegradation [ | Soft and heterostructured g-C3N4@Co-TiO2 (CNCT) nanofibrous membranes. Method: electrospinning and thermal polymerization process for Co-TiO2 nanofiber: PVP ethanol solution with TiO2 sol (1/1 ratio), stirred 1 h, electrospinning, fibrous membranes obtained calcined at 600 °C, 60 min, air. TiO2 sol preparation: mixture of TIP, Co(NO3)2·6H2O, EtOH, and HAc (1/0.03/3/3 ratio). In situ synthesized g-C3N4 nanoshell wrapped onto Co-TiO2 nanofiber as core-shell quantum heterojunction. Diameters: 305 nm Co-TiO2, 320 and 338 nm for CNCT-3 and CNCT-5 membranes (different melamine content). | Antibiotics (20 mg/L, pH 7): tetracycline hydrochloride (TC-H), doxycycline hydrochloride (DC-H), oxytetracycline hydrochloride (OTC-H), CIP. Degradation efficiency: 82.3 (CNCT-1), 90.8 (CNCT-3), and 75.7% (CNCT-5) for TC-H, 60 min. 60.2, 75.3, 82.2% for CIP, OTC-H, DC-H, visible light, 60 min. |
Membrane materials used in EP separation processes.
| Type of Process | Membrane Material | EP Type/Category, Source | Performances/Limitations |
|---|---|---|---|
| MF | polyether sulfone (PES), cellulose acetate (CA), nitrocellulose, | 0.2 μM (46–59 μg/L) compound spiked solutions: estrone (E1), 17β-estradiol (E2), 17α-ethynylestradiol (EE2), BPA; domestic wastewater. | E1 (0.44 μg/cm2), E2 (0.82 μg/cm2), EE2 (1.23 μg/cm2), BPA (0.32 μg/cm2). |
| MF | zeolite imidazolate metal-organic framework (ZIF-8) nanoparticles incorporated into poly(tetrafluoroethylene) | hormones: progesterone (PGS) (0.5–5.0 mg/L); waste streams | 95% PGS. High adsorption capacity and fouling tolerance, high porosity, low cost, efficient regeneration, ease operation. |
| MF | hybrid composite membranes: TiO2/PES, TiO2/PVDF. | diclofenac (25 mg/L), ibuprofen (100 mg/L); wastewaters. | Diclofenac: 68% in 120 min for TiO2/PES membrane; 55% in 120 min for TiO2/PVDF membrane. |
| MF-RO | Hybrid hollow fiber MF-RO membranes: MF polysulfone, RO polyamide. | Pharmaceuticals: carbamazepine, diclofenac, atenolol, azithromycin erythromycin etc., and pesticides between 162–240 ng/L. wastewater treatment plant. | Pharmaceuticals and pesticides: 98% and 100% (MF permeate: higher than 100 ng/L, RO ng/L or below the LOQs). MF-RO 97% for the most pharmaceuticals. RO pesticides: 67% 90%, 88% for diazinon, diuron, and 2,4 D.78 and 99% for MCPA and other pesticides, 97, 98% for MCPA and mecoprop. |
| MF | CNT composite PVDF membranes. | Triclosan (TCS), acetaminophen (AAP), ibuprofen (IBU) 1 mg/L. | 10–95%, increase with number of aromatic rings (AAP/IBU/TCS). |
| NF and RO [ | polyamide thin-film | analgesics and anti-inflammatory drugs (ketoprofen < MQL–314 ng/L, diclofenac 60.2–219.4 ng/L, propyphenazone 51.5–295.8 ng/L), b-blockers, antiepileptic drug carbamazepine 8.7–166.5 ng/L, antibiotics, lipid regulator (gemfibrozil), diuretic as hydrochlorothiazide (58.6–2548 ng/L). full-scale drinking water treatment plant (DWTP) using groundwater. | NF and RO membranes: acetaminophen |
| UF with coagulation and disk filtration [ | hollow-fiber PVDF UF membrane and spiral-wound polyamide type TFC RO membranes combined with coagulation and disk filtration (CC–DF). | Micropolluants: atenolol (ATE), carbamazepine (CBZ), caffeine (CAF), diclofenac (DIC), dilatin (DIL), florfenicol (FLO), and sulfamethoxazole (SMX), A pilot-scale municipal wastewater system. | UF membrane (<17%), the RO membrane high removal efficiencies (91–98%), especially for negatively charged micropolluants (i.e., DIC and SMX) compared to the noncharged micropollutatns (CBZ, CAF, DIL) and/or positively charged micropollutants. |
| UF/NF | micellar-enhanced ultrafiltration (MEUF) with polyethersulfone (UF) and cellulose acetate, polysulfone–polyamide thin film (NF). | 11 ECs: acetaminophen (ACET), metoprolol | Cationic surfactants cetyl pyridinium chloride (CPC)/cetyl trimethyl ammonium bromide (CTAB), pH 7.9 for: ATR 62/65.8% and ISOP 68.8/67.5%, Retention 95/85%: DIC > KET > SUL > FLUM (accordingly to the pKa values). |
| UF | thin-film composite, cross-linked aromatic polyamide top layer, and PT polyethersulfone membrane. | amoxicillin, naproxen, metoprolol and phenacetin. | The retention coefficients with the UF membranes followed the sequence naproxen > metoprolol > amoxicillin > phenacetin, and with the NF membranes:amoxicillin > naproxen > metoprolol > phenacetin. |
| NF | commercial NF-270, 800 kPa pressure. | Carbamazepine, BPA, triclosan, butyl benzyl phthalate, and 4- | Removal increased for hydrophobic compounds due to adsorption onto membranes (>90%), while water solubility reduced the retention of BPA. |
| NF | commercial NF-90 and NF-270 membranes. | sulfamethoxazole, diclofenac sodium, hydrochlorothiazide, | Solute retention for NF-90: >95%, NF-270: from 75% (for nicotine) to 95% (for ranitidine hydrochloride). |
| NF | polyamide membrane | estrone and estradiol Aqueous solutions. | Polyamide NF membranes the highest hormone adsorption. |
| NF | grafted polyamide membranes with methacrylic acid cross-linked with ethylene diamine (ED). | Pharmaceutically active compounds: BPA, ibuprofen and salicylic acid. | 95% rejection for BPA, 74% rejection with pristine membrane. |
| NF | NF hollow fiber membrane dry-jet wet spinning using a hyperbranched polyethyleneimine (PEI) as cross-linker. | 20 ppm CPF. Synthetic solution. | pH 3 and positively charged PEI modified NF hollow fiber membranes: 99% rejections. pH increased with rejection decreased (CPF molecules become less positively charged). |
| NF | thin polyamide skin layer on top of a microporous polysulfone support. | sulfamethoxazole, carbamazepine, and ibuprofen. Pharmaceuticals spiked, 500 g/L. | Sulfamethoxazole and ibuprofen (negatively charged) retention increased with ionic strength increasing. |
| NF | commercial NF membrane based on TFC. | norfloxacin (NOR), ofloxacin (OFL), roxithromycin (ROX), azithromycin. Wastewater treatment plant. | 98% rejections. UV/O3 process, removal efficiencies: 87%, with 40% dissolved organic carbon (DOC), 58% acute toxicity reduction. |